PUBLISHER: TechNavio | PRODUCT CODE: 1723063
PUBLISHER: TechNavio | PRODUCT CODE: 1723063
The in-vitro diagnostics instruments market is forecasted to grow by USD 60.9 bn during 2024-2029, accelerating at a CAGR of 9.8% during the forecast period. The report on the in-vitro diagnostics instruments market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, demand for personalized medicines, and product launches.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 8.7% |
CAGR | 9.8% |
Incremental Value | $60.9 bn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's in-vitro diagnostics instruments market is segmented as below:
By Product
By End-user
By Application
By Geographical Landscape
This study identifies the potential opportunities for physician office laboratories (POL) as one of the prime reasons driving the in-vitro diagnostics instruments market growth during the next few years. Also, leasing of ivd instruments and technological advances in ivd will lead to sizable demand in the market.
The report on the in-vitro diagnostics instruments market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in-vitro diagnostics instruments market vendors that include Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Biosino Bio Technology and Science Inc, CPC Diagnostics Pvt Ltd., DAAN Gene Co. Ltd., DiaSorin S.p.A., F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Hologic Inc., QIAGEN N.V., QuidelOrtho Corp., Shanghai Kehua Bio Engineering Co. Ltd., Shenzhen Mindray BioMedical Electronics Co. Ltd., Siemens Healthineers AG, Sysmex Corp., and Thermo Fisher Scientific Inc.. Also, the in-vitro diagnostics instruments market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: